Error: Could not add to watchlist. X

Tekla Life Sciences Investors

+ Watchlist
HQL:US
New York
28.54
USD
0.33
1.17%
As of 20:04:06 ET on 07/02/2015.
Open
28.41
Day Range
28.37 - 28.58
Volume
75,190
Previous Close
28.21
52Wk Range
19.24 - 29.20
1 Yr Return
44.75%
NAV (on 07/01/2015)
29.02
Total Assets (m USD) (on 06/26/2015)
562.317
Inception Date
05/08/1992
Premium/Discount
-1.65%
Average 52-Week Premium
-1.27%
Fund Managers
DANIEL R OMSTEAD "DAN"
Last Dividend (on 05/22/2015)
0.54
Dividend Indicated Gross Yield
7.57%
Expense Ratio
1.32%
3 Mo Return
4.30%
3 Yr Return
35.07%
5 Yr Return
38.53%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 563.82 k 60.02 m 13.52
Celgene Corp 436.32 k 41.35 m 9.31
Vertex Pharmaceuticals Inc 206.56 k 23.20 m 5.22
Alexion Pharmaceuticals Inc 127.80 k 21.19 m 4.77
Regeneron Pharmaceuticals Inc 54.52 k 19.66 m 4.43
Amgen Inc 136.59 k 19.19 m 4.32
Biogen Inc 54.18 k 17.92 m 4.04
Incyte Corp 259.92 k 12.75 m 2.87
Allergan plc 46.82 k 11.30 m 2.54
Shire PLC 37.38 k 9.68 m 2.18
Profile
Tekla Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies and primarily in securities of public and private companies that are believed to have significant potential for above-average growth.
ADDRESS
H & Q Investors
2 Liberty Square, 9th Floor
Boston, MA 02109
USA
PHONE
1-617-772-8500